Organovo designs and creates functional human tissues using a proprietary three dimensional bioprinting technology. The Company focuses on developing a range of human tissues and disease models for medical research and therapeutic applications. The Company s NovoGen three dimensional bioprinting technology employs a specialized automated platform that works across all tissue and cell types. Organovo s bioprinter was named one of the Best Inventions of by TIME Magazine and Organovo has been recognized as one of the most innovative companies of by MIT s Technology Review. Organovo is helping pharmaceutical partners develop never before available human biological disease models in three dimensions that hold the potential to transform the business of therapeutic drug discovery and development. Organovo is also developing direct tissue therapies where precise structure and architecture may deliver the best clinical outcomes. Organovo leads the way in solving complex medical research problems and building the future of medicine.
Quote | Organovo Holdings Inc. (NASDAQ:ONVO)
Last: | $0.62 |
---|---|
Change Percent: | 5.6% |
Open: | $0.64 |
Close: | $0.62 |
High: | $0.6666 |
Low: | $0.55 |
Volume: | 1,448,854 |
Last Trade Date Time: | 07/16/2024 03:00:00 am |
News | Organovo Holdings Inc. (NASDAQ:ONVO)
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
SAN DIEGO, July 16, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today announced that Executive Chairman Keith Murphy presen...
Message Board Posts | Organovo Holdings Inc. (NASDAQ:ONVO)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $ONVO News Article - Organovo Announces FXR Program | whytestocks | investorshangout | 03/21/2023 12:45:49 PM |
$ONVO...........................https://stockcharts.com/h-sc/ui?s=$ONVO&p=W&b=5&g= | glenn1919 | investorshub | 02/18/2023 12:28:53 PM |
this needs to get pumped by Redditors | starbuxsux | investorshub | 02/16/2023 7:42:40 PM |
When it reaches 72$/share, I'll have fun lol | phytokaiser1 | investorshub | 02/16/2023 5:13:04 PM |
Im having fun anyone else? | Awl416 | investorshub | 02/16/2023 5:07:41 PM |
News, Short Squeeze, Breakout and More Instantly...
Organovo Holdings Inc. Company Name:
ONVO Stock Symbol:
NASDAQ Market:
Organovo Holdings Inc. Website:
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
SAN DIEGO, July 16, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today announced that Executive Chairman Keith Murphy presen...